{"schema_version":"secwatch.filing_event.v1","accession":"0001051514-21-000066","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2021-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.280299+00:00","generated_at":"2026-06-28T23:17:32.831693+00:00","sec_items":["1.01","1.02","2.03","3.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"STRATA secures $8M MidCap loan, repays prior debt; names Christopher Lesovitz as new CFO","bullets":["Entered $8M senior secured term loan with MidCap Financial Trust, drawn Sep 30, 2021; interest at LIBOR (0.50% floor) + 7.50%; matures Sep 1, 2026.","Repaid $7.275M IDBNY loan and $500K SBA EIDL loan; old debt terminated.","CFO Matthew Hill resigns effective Oct 15; internal promotion: Christopher Lesovitz named CFO effective Oct 16, 2021.","Lesovitz receives $250K base salary, up to 50% bonus, $1K/mo car allowance, and options for 250K shares at Oct 18 close.","MidCap received warrant for 373,626 shares at $1.82, expiring Sep 30, 2031; financial covenant: min trailing rev $24M rising to $30M."],"urls":{"canonical":"https://secwatch.observer/filing/0001051514-21-000066","json":"https://secwatch.observer/filing/0001051514-21-000066.json","markdown":"https://secwatch.observer/filing/0001051514-21-000066.md","text":"https://secwatch.observer/filing/0001051514-21-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/0001051514-21-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:17:32.831693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e824ff812","claim":"Christopher Lesovitz was appointed as Chief Financial Officer at STRATA Skin Sciences, Inc..","evidence_excerpt":"Effective October 16, 2021, the Company appointed Christopher Lesovitz (age 39) as its Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/0001051514-21-000066-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"802d1aed5f","claim":"Matthew C. Hill resigned as Chief Financial Officer at STRATA Skin Sciences, Inc..","evidence_excerpt":"On October 4, 2021, Matthew C. Hill, the Company’s Chief Financial Officer, notified the Company of his resignation effective October 15, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151421000066/0001051514-21-000066-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}